
Kadence Bio
Developer of a small-molecule therapeutic designed to address significant unmet needs in sexual and mental well-being. The company offers a clinical-stage treatment for premature ejaculation, enabling...
Valuation
$0
Share Price
N/A
Total Raised
$16.3M
Last Round
N/A